Chinook Therapeutics
KDNY
#4181
Rank
โ‚ฌ2.31 B
Marketcap
34,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
84.03%
Change (1 year)

Revenue for Chinook Therapeutics (KDNY)

Revenue in 2023 (TTM): โ‚ฌ5.63 Million

According to Chinook Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ5.01 Million. In 2022 the company made a revenue of โ‚ฌ5.71 Million a decrease over the revenue in the year 2021 that were of โ‚ฌ45.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Chinook Therapeutics from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ5.63 M-1.28%
2022 โ‚ฌ5.71 M-87.47%
2021 โ‚ฌ45.58 M1115.19%
2020 โ‚ฌ3.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA